News & Events » 2007

Sep 2007
Dr. Eduardo Perez, PhD, awarded 2nd year NJCST fellowship ($85K) to continue his research efforts.

Sep 2007
Dr. Michael Voronkov, PhD, joins Signum Biosciences as Director of Medicinal Chemistry and Product Development.

Jul 2007
Signum Biosciences closes $2.5 million Series A-2 private placement.

Jul 2007
Dr. Gregory Stock, PhD, discusses Signum Biosciences research and business on HealthDot with Scribe Media and describe Signum Technology in opening keynote "New Approaches to Healthcare" at the World Future Society, Minneapolis.

Jun 2007
Collaborative research effort at Princeton University (including Dr. Jeffry Stock) determines the “Structural and biochemical insights into the regulation of PP2A by ST antigen of SV40” (published in Nature Structural & Molecular Biology).

Apr 2007
Signum Biosciences closes $1 million loan from the New Jersey Economic Development Authority (NJEDA).

Apr 2007
Dr. Gregory Stock, PhD, discusses Signum Biosciences innovative research strategy on NPR’s Biotech Nation and showcases Signum’s dermatology technology at industry panel "Dermatology Enigma:Exploring the Disconnect between Unmet Needs and Pharma Investment" at Therapeutic Insights Conference, New York.

Mar 2007
Lee Humphreys joins Signum Biosciences as VP of business development.

Jan 2007
Signum Biosciences completes a Series A-1 private placement for $1.8 million.